Literature DB >> 11703366

Beta-cell, thyroid, gastric, adrenal and coeliac autoimmunity and HLA-DQ types in type 1 diabetes.

C E De Block1, I H De Leeuw, J J Vertommen, R P Rooman, M V Du Caju, C M Van Campenhout, J J Weyler, F Winnock, J Van Autreve, F K Gorus.   

Abstract

The autoimmune attack in type 1 diabetes is not only targeted to beta cells. We assessed the prevalence of thyroid peroxidase (aTPO), parietal cell (PCA), antiadrenal (AAA) and endomysial antibodies (EmA-IgA), and of overt autoimmune disease in type 1 diabetes, in relation to gender, age, duration of disease, age at onset, beta-cell antibody status (ICA, GADA, IA2A) and HLA-DQ type. Sera from 399 type 1 diabetic patients (M/F: 188/211; mean age: 26 +/- 16 years; duration: 9 +/- 8 years) were tested for ICA, PCA, AAA and EmA-IgA by indirect immunofluorescence, and for IA2A (tyrosine phosphatase antibodies), GADA (glutamic acid decarboxylase-65 antibodies) and aTPO by radiobinding assays. The prevalence rates were: GADA 70%; IA2A, 44%; ICA, 39%; aTPO, 22%; PCA, 18%; EmA-IgA, 2%; and AAA, 1%. aTPO status was determined by female gender (beta = - 1.15, P = 0.002), age (beta = 0.02, P = 0.01) and GADA + (beta = 1.06, P = 0.02), but not by HLA-DQ type or IA2A status. Dysthyroidism (P < 0.0001) was more frequent in aTPO + subjects. PCA status was determined by age (beta = 0.03, P = 0.002). We also observed an association between PCA + and GADA + (OR = 1.9, P = 0.049), aTPO + (OR = 1.9, P = 0.04) and HLA DQA1*0501-DQB1*0301 status (OR = 2.4, P = 0.045). Iron deficiency anaemia (OR = 3.0, P = 0.003) and pernicious anaemia (OR = 40, P < 0.0001) were more frequent in PCA + subjects. EmA-IgA + was linked to HLA DQA1*0501-DQB1*0201 + (OR = 7.5, P = 0.039), and coeliac disease was found in three patients. No patient had Addison's disease. In conclusion, GADA but not IA2A indicate the presence of thyrogastric autoimmunity in type 1 diabetes. aTPO have a female preponderance, PCA are weakly associated with HLA DQA1*0501-DQB1*0301 and EmA-IgA + with HLA DQA1*0501-DQB1*0201.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11703366      PMCID: PMC1906197          DOI: 10.1046/j.1365-2249.2001.01668.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  37 in total

Review 1.  Comparative genetics of type 1 diabetes and autoimmune disease: common loci, common pathways?

Authors:  K G Becker
Journal:  Diabetes       Date:  1999-07       Impact factor: 9.461

Review 2.  The genetics of Graves' disease.

Authors:  S C Gough
Journal:  Endocrinol Metab Clin North Am       Date:  2000-06       Impact factor: 4.741

Review 3.  The genetics of Hashimoto's disease.

Authors:  G Barbesino; L Chiovato
Journal:  Endocrinol Metab Clin North Am       Date:  2000-06       Impact factor: 4.741

Review 4.  Population screening for autoimmune thyroid disease.

Authors:  W M Tunbridge; M P Vanderpump
Journal:  Endocrinol Metab Clin North Am       Date:  2000-06       Impact factor: 4.741

5.  Autoantibodies to tissue transglutaminase are sensitive serological parameters for detecting silent coeliac disease in patients with Type 1 diabetes mellitus.

Authors:  O Kordonouri; W Dieterich; D Schuppan; G Webert; C Müller; N Sarioglu; M Becker; T Danne
Journal:  Diabet Med       Date:  2000-06       Impact factor: 4.359

6.  High prevalence of manifestations of gastric autoimmunity in parietal cell antibody-positive type 1 (insulin-dependent) diabetic patients. The Belgian Diabetes Registry.

Authors:  C E De Block; I H De Leeuw; L F Van Gaal
Journal:  J Clin Endocrinol Metab       Date:  1999-11       Impact factor: 5.958

7.  High frequency of persisting or increasing islet-specific autoantibody levels after diagnosis of type 1 diabetes presenting before 40 years of age. The Belgian Diabetes Registry.

Authors:  K Decochez; J Tits; J L Coolens; L Van Gaal; G Krzentowski; F Winnock; E Anckaert; I Weets; D G Pipeleers; F K Gorus
Journal:  Diabetes Care       Date:  2000-06       Impact factor: 19.112

8.  Antibodies to tissue transglutaminase C in type I diabetes.

Authors:  V Lampasona; R Bonfanti; E Bazzigaluppi; A Venerando; G Chiumello; E Bosi; E Bonifacio
Journal:  Diabetologia       Date:  1999-10       Impact factor: 10.122

9.  Combined use of autoantibodies (IA-2 autoantibody, GAD autoantibody, insulin autoantibody, cytoplasmic islet cell antibodies) in type 1 diabetes: Combinatorial Islet Autoantibody Workshop.

Authors:  C F Verge; D Stenger; E Bonifacio; P G Colman; C Pilcher; P J Bingley; G S Eisenbarth
Journal:  Diabetes       Date:  1998-12       Impact factor: 9.461

10.  Disease-associated autoantibodies and HLA-DQB1 genotypes in children with newly diagnosed insulin-dependent diabetes mellitus (IDDM). The Childhood Diabetes in Finland Study Group.

Authors:  E Sabbah; K Savola; P Kulmala; H Reijonen; R Veijola; P Vähäsalo; J Karjalainen; J Ilonen; H K Akerblom; M Knip
Journal:  Clin Exp Immunol       Date:  1999-04       Impact factor: 4.330

View more
  21 in total

Review 1.  Polyspecificity of autoimmune responses in type 1 (autoimmune) diabetes.

Authors:  L M Esteban; A G Baxter
Journal:  Clin Exp Immunol       Date:  2001-11       Impact factor: 4.330

2.  Gliadin, endomysial and thyroid antibodies in patients with latent autoimmune diabetes of adults (LADA).

Authors:  P Kucera; D Nováková; M Behanová; J Novak; H Tlaskalová-Hogenová; M Andel
Journal:  Clin Exp Immunol       Date:  2003-07       Impact factor: 4.330

3.  Italian Association of Clinical Endocrinologists (AME) & Italian Association of Clinical Diabetologists (AMD) Position Statement : Diabetes mellitus and thyroid disorders: recommendations for clinical practice.

Authors:  Edoardo Guastamacchia; Vincenzo Triggiani; Alberto Aglialoro; Antimo Aiello; Lucia Ianni; Mauro Maccario; Michele Zini; Carlo Giorda; Rinaldo Guglielmi; Corrado Betterle; Roberto Attanasio; Giorgio Borretta; Piernicola Garofalo; Enrico Papini; Roberto Castello; Antonio Ceriello
Journal:  Endocrine       Date:  2014-11-18       Impact factor: 3.633

4.  The Oslo definitions for coeliac disease and related terms.

Authors:  Jonas F Ludvigsson; Daniel A Leffler; Julio C Bai; Federico Biagi; Alessio Fasano; Peter H R Green; Marios Hadjivassiliou; Katri Kaukinen; Ciaran P Kelly; Jonathan N Leonard; Knut Erik Aslaksen Lundin; Joseph A Murray; David S Sanders; Marjorie M Walker; Fabiana Zingone; Carolina Ciacci
Journal:  Gut       Date:  2012-02-16       Impact factor: 23.059

5.  Type 1 Diabetes and Thyroid Autoimmunity in Children.

Authors:  Anca Orzan; Carmen Novac; Mihaiela Mihu; Constantin Ionescu Tirgoviste; Mihaela Balgradean
Journal:  Maedica (Bucur)       Date:  2016-12

6.  A quarter of patients with type 1 diabetes have co-existing non-islet autoimmunity: the findings of a UK population-based family study.

Authors:  A Kozhakhmetova; R C Wyatt; C Caygill; C Williams; A E Long; K Chandler; R J Aitken; J M Wenzlau; H W Davidson; K M Gillespie; A J K Williams
Journal:  Clin Exp Immunol       Date:  2018-03-24       Impact factor: 4.330

7.  [Alopecia totalis, hypotension and erectile dysfunction in a 34 year old patient. Difficult clarification of a common cause].

Authors:  W Hunger-Dathe; A Braun; U A Müller
Journal:  Internist (Berl)       Date:  2005-06       Impact factor: 0.743

8.  Heritability of thyroid peroxidase autoantibody levels in type 1 diabetes: evidence from discordant twin pairs.

Authors:  Bin Wang; Mohammed I Hawa; Frühling V Rijsdijk; Pamela R Fain; Stavroula A Paschou; Bernhard O Boehm; Andrea K Steck; Harold Snieder; R David G Leslie
Journal:  Diabetologia       Date:  2015-06-13       Impact factor: 10.122

9.  Polyendocrinopathy in children, adolescents, and young adults with type 1 diabetes: a multicenter analysis of 28,671 patients from the German/Austrian DPV-Wiss database.

Authors:  Katharina Warncke; Elke E Fröhlich-Reiterer; Angelika Thon; Sabine E Hofer; Dagobert Wiemann; Reinhard W Holl
Journal:  Diabetes Care       Date:  2010-06-14       Impact factor: 19.112

10.  Factors for thyroid autoimmunity in children and adolescents with type 1 diabetes mellitus.

Authors:  Kostas Kakleas; Evangelia Paschali; Nikos Kefalas; Aspasia Fotinou; Maria Kanariou; Christina Karayianni; Kyriaki Karavanaki
Journal:  Ups J Med Sci       Date:  2009       Impact factor: 2.384

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.